Each person's response to each medicine may vary. According to a systematic review of several studies, both medications are effective for the short-term treatment of major depressive disorder. Another ...

Among the myriad drugmakers laying out their plans for the future at this year’s J.P. Morgan Healthcare Conference, Takeda ...

The narcolepsy treatment market is projected to grow from USD 5,301.6 million in 2024 to USD 8,718.3 million by 2034, at a ...

Tens of thousands of Australians helped contribute to the world's largest study into depression genetics, generating hope ...